Announced March 19, 2026
CVS cash pricing on FDA-approved tirzepatide in 2026: Mounjaro (any dose pen, 30-day supply): $1,050 to $1,150 Zepbound (any dose pen, 28-day supply): $1,059 to $1,200 LillyDirect Zepbound 2.5 mg vial: $349 per month LillyDirect Zepbound 5 mg vial: $499 per month LillyDirect Zepbound 7.5 mg or 10 mg vial: $599 to $699 per month CVS pricing sits among the highest of the major chains
Reported cases have occurred primarily in diabetic patients with significant renal insufficiency, including both intrinsic renal disease and renal hypoperfusion, often in the setting of multiple concomitant medical/surgical problems and multiple concomitant medications
And before I tell you the first way that they might help, I need you to understand something that most people are never told, and that is
If prescribed, the cost depends on the medication type and dosage